Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis

Open access
Li, Dong-Yang, Hao, Xuan-Yu, Ma, Tian-Ming, Dai, Hui-Xu, Song, Yong-Sheng · 2017 · Scientific Reports

Abstract

The relationship of platelet-to-lymphocyte ratio (PLR) and survival in urological cancers remained inconsistent in previous studies. Therefore, we performed a meta-analysis to assess the prognostic significance of PLR in patients with urological cancers. A literature search was performed in the PubMed, Embase, and Web of Science up to July, 2017 and study quality was obtained using the Newcastle-Ottawa Scale. To estimate the association of PLR and overall survival (OS) and other survival outcomes in urological cancers, we used pooled hazard ratios (HRs). Subgroup analyses were conducted on different ethnics, sample sizes and cut-off values. 20 high quality studies involving 7562 patients with urological cancers were included in this meta-analysis. High pretreatment PLR was significantly associated with poor OS in patients with urological cancers (pooled HR = 1.58). Elevated PLR was also correlated with other survival outcomes. However, we found that PLR was significantly relevant to the OS of patients with different types of urological cancers except bladder cancer (BCa, HR = 1.16, 95%CI: 0.96–1.41). In conclusion, elevated PLR was negatively related to the OS of patients with urological cancers, except in BCa. However, more large scale prospective studies with high quality are required in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-15673-2

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow chart of literature search and study selection.
Figure 1 Flow chart of literature search and study selection.CC BY · PubMed Central
Figure 2 Forest plot of pooled HR of PLR in predicting survival outcomes in urological cancers. (a) PLR and OS. (b) PLR and CSS. (c) PLR and PFS. (d) PLR and DFS.
Figure 2 Forest plot of pooled HR of PLR in predicting survival outcomes in urological cancers. (a) PLR and OS. (b) PLR and CSS. (c) PLR and PFS. (d) PLR and DFS.CC BY · PubMed Central
Figure 3 Forest plots of pooled HR of PLR in predicting OS in different types of urological cancers. (a) PLR in RCC. (b) PLR in PCa. (c) PLR in BCa. (d) PLR in UTUC.
Figure 3 Forest plots of pooled HR of PLR in predicting OS in different types of urological cancers. (a) PLR in RCC. (b) PLR in PCa. (c) PLR in BCa. (d) PLR in UTUC.CC BY · PubMed Central
Figure 4 Forest plots of pooled HR of PLR in predicting OS in different subgroups. (a) Asains. (b) Non-Asians. (c) PLR value > 150. (d) PLR value ≤ 150. (e) Sample size > 254. (f) Sample size ≤ 254.
Figure 4 Forest plots of pooled HR of PLR in predicting OS in different subgroups. (a) Asains. (b) Non-Asians. (c) PLR value > 150. (d) PLR value ≤ 150. (e) Sample size > 254. (f) Sample size ≤ 254.CC BY · PubMed Central
Figure 5 Sensitivity analysis of included studies. (a) PLR and OS. (b) PLR and CSS. (c) PLR and PFS. (d) PLR and DFS.
Figure 5 Sensitivity analysis of included studies. (a) PLR and OS. (b) PLR and CSS. (c) PLR and PFS. (d) PLR and DFS.CC BY · PubMed Central
Figure 6 Plots of Egger’s test. (a) PLR and OS. (b) PLR and CSS. (c) PLR and PFS. (d) PLR and DFS.
Figure 6 Plots of Egger’s test. (a) PLR and OS. (b) PLR and CSS. (c) PLR and PFS. (d) PLR and DFS.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Research works printed but not linked: 2

  1. Ding, N. et al. The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort. Sci Rep 6, 34823 (2016). · DOI
  2. Zhu, Y. et al. Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer. Oncotarget 8, 1023–1030 (2017). · DOI

Cited by

See all 45

Metadata

Authors
Li, D.-Y., Hao, X.-Y., Ma, T.-M., Dai, H.-X., & Song, Y.-S.
Venue
Scientific Reports
Published
2017-11-13
Volume
7
Issue
1
Pages
15387-15387
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2767673463
Cited by
44
References
51
Citations by year
2026: 2 · 2025: 5 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 5 · 2020: 4 · 2019: 7 · 2018: 8
FWCI
0.55
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
Keywords
platelet-to-lymphocyte ratio, genitourinary cancer, prognostic factors, overall survival, bladder cancer, prognostic value
MeSH terms
Blood Platelets, Female, Humans, Lymphocytes, Male, Platelet Count, Urologic Neoplasms, Survival Rate, Disease-Free Survival, Lymphocyte Count

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis. https://app.cochat.ai/papers/10.1038/s41598-017-15673-2
The paper
Li, D.-Y., Hao, X.-Y., Ma, T.-M., Dai, H.-X., & Song, Y.-S. (2017). The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis. Scientific Reports. https://doi.org/10.1038/s41598-017-15673-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.